1 Market Overview

1.1 Product Overview and Scope of In-Vitro Toxicology and Toxicity Testing

1.2 Classification of In-Vitro Toxicology and Toxicity Testing by Type

1.2.1 Overview: Global In-Vitro Toxicology and Toxicity Testing Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type in 2021

1.2.3 Cell Culture Technology

1.2.4 High Throughput Technologies

1.2.5 Molecular Imaging Technologies

1.2.6 Omics Technologies

1.3 Global In-Vitro Toxicology and Toxicity Testing Market by Application

1.3.1 Overview: Global In-Vitro Toxicology and Toxicity Testing Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Pharmaceutical Industry

1.3.3 Chemical Industry

1.3.4 Food Industry

1.3.5 Other

1.4 Global In-Vitro Toxicology and Toxicity Testing Market Size & Forecast

1.5 Global In-Vitro Toxicology and Toxicity Testing Market Size and Forecast by Region

1.5.1 Global In-Vitro Toxicology and Toxicity Testing Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global In-Vitro Toxicology and Toxicity Testing Market Size by Region, (2017-2022)

1.5.3 North America In-Vitro Toxicology and Toxicity Testing Market Size and Prospect (2017-2028)

1.5.4 Europe In-Vitro Toxicology and Toxicity Testing Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size and Prospect (2017-2028)

1.5.6 South America In-Vitro Toxicology and Toxicity Testing Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa In-Vitro Toxicology and Toxicity Testing Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 In-Vitro Toxicology and Toxicity Testing Market Drivers

1.6.2 In-Vitro Toxicology and Toxicity Testing Market Restraints

1.6.3 In-Vitro Toxicology and Toxicity Testing Trends Analysis

2 Company Profiles

2.1 GE Healthcare

2.1.1 GE Healthcare Details

2.1.2 GE Healthcare Major Business

2.1.3 GE Healthcare In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.1.4 GE Healthcare In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 GE Healthcare Recent Developments and Future Plans

2.2 Thermo Fisher Scientific

2.2.1 Thermo Fisher Scientific Details

2.2.2 Thermo Fisher Scientific Major Business

2.2.3 Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.2.4 Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.3 Bio-Rad Laboratories

2.3.1 Bio-Rad Laboratories Details

2.3.2 Bio-Rad Laboratories Major Business

2.3.3 Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.3.4 Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.4 Agilent Technologies

2.4.1 Agilent Technologies Details

2.4.2 Agilent Technologies Major Business

2.4.3 Agilent Technologies In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.4.4 Agilent Technologies In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Agilent Technologies Recent Developments and Future Plans

2.5 Cyprotex

2.5.1 Cyprotex Details

2.5.2 Cyprotex Major Business

2.5.3 Cyprotex In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.5.4 Cyprotex In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Cyprotex Recent Developments and Future Plans

2.6 Covance

2.6.1 Covance Details

2.6.2 Covance Major Business

2.6.3 Covance In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.6.4 Covance In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Covance Recent Developments and Future Plans

2.7 Bioreliance

2.7.1 Bioreliance Details

2.7.2 Bioreliance Major Business

2.7.3 Bioreliance In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.7.4 Bioreliance In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Bioreliance Recent Developments and Future Plans

2.8 Catalent

2.8.1 Catalent Details

2.8.2 Catalent Major Business

2.8.3 Catalent In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.8.4 Catalent In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Catalent Recent Developments and Future Plans

2.9 Charles River Laboratories International

2.9.1 Charles River Laboratories International Details

2.9.2 Charles River Laboratories International Major Business

2.9.3 Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.9.4 Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Charles River Laboratories International Recent Developments and Future Plans

2.10 Alere

2.10.1 Alere Details

2.10.2 Alere Major Business

2.10.3 Alere In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.10.4 Alere In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Alere Recent Developments and Future Plans

2.11 Eurofins Scientific

2.11.1 Eurofins Scientific Details

2.11.2 Eurofins Scientific Major Business

2.11.3 Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.11.4 Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Eurofins Scientific Recent Developments and Future Plans

2.12 Life Technologies Corporation

2.12.1 Life Technologies Corporation Details

2.12.2 Life Technologies Corporation Major Business

2.12.3 Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.12.4 Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Life Technologies Corporation Recent Developments and Future Plans

2.13 Quest Diagnostics

2.13.1 Quest Diagnostics Details

2.13.2 Quest Diagnostics Major Business

2.13.3 Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Product and Solutions

2.13.4 Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Quest Diagnostics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global In-Vitro Toxicology and Toxicity Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 In-Vitro Toxicology and Toxicity Testing Players Market Share in 2021

3.2.2 Top 10 In-Vitro Toxicology and Toxicity Testing Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 In-Vitro Toxicology and Toxicity Testing Players Head Office, Products and Services Provided

3.4 In-Vitro Toxicology and Toxicity Testing Mergers & Acquisitions

3.5 In-Vitro Toxicology and Toxicity Testing New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global In-Vitro Toxicology and Toxicity Testing Revenue and Market Share by Type (2017-2022)

4.2 Global In-Vitro Toxicology and Toxicity Testing Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Application (2017-2022)

5.2 Global In-Vitro Toxicology and Toxicity Testing Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America In-Vitro Toxicology and Toxicity Testing Revenue by Type (2017-2028)

6.2 North America In-Vitro Toxicology and Toxicity Testing Revenue by Application (2017-2028)

6.3 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country

6.3.1 North America In-Vitro Toxicology and Toxicity Testing Revenue by Country (2017-2028)

6.3.2 United States In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

6.3.3 Canada In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

6.3.4 Mexico In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe In-Vitro Toxicology and Toxicity Testing Revenue by Type (2017-2028)

7.2 Europe In-Vitro Toxicology and Toxicity Testing Revenue by Application (2017-2028)

7.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country

7.3.1 Europe In-Vitro Toxicology and Toxicity Testing Revenue by Country (2017-2028)

7.3.2 Germany In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

7.3.3 France In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

7.3.4 United Kingdom In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

7.3.5 Russia In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

7.3.6 Italy In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Revenue by Type (2017-2028)

8.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Revenue by Application (2017-2028)

8.3 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region

8.3.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Revenue by Region (2017-2028)

8.3.2 China In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

8.3.3 Japan In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

8.3.4 South Korea In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

8.3.5 India In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

8.3.7 Australia In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America In-Vitro Toxicology and Toxicity Testing Revenue by Type (2017-2028)

9.2 South America In-Vitro Toxicology and Toxicity Testing Revenue by Application (2017-2028)

9.3 South America In-Vitro Toxicology and Toxicity Testing Market Size by Country

9.3.1 South America In-Vitro Toxicology and Toxicity Testing Revenue by Country (2017-2028)

9.3.2 Brazil In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

9.3.3 Argentina In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Revenue by Type (2017-2028)

10.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Revenue by Application (2017-2028)

10.3 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country

10.3.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Revenue by Country (2017-2028)

10.3.2 Turkey In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

10.3.4 UAE In-Vitro Toxicology and Toxicity Testing Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global In-Vitro Toxicology and Toxicity Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global In-Vitro Toxicology and Toxicity Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market In-Vitro Toxicology and Toxicity Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global In-Vitro Toxicology and Toxicity Testing Revenue (USD Million) by Region (2017-2022)

Table 5. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Region (2023-2028)

Table 6. GE Healthcare Corporate Information, Head Office, and Major Competitors

Table 7. GE Healthcare Major Business

Table 8. GE Healthcare In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 9. GE Healthcare In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 11. Thermo Fisher Scientific Major Business

Table 12. Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 13. Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 15. Bio-Rad Laboratories Major Business

Table 16. Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 17. Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 19. Agilent Technologies Major Business

Table 20. Agilent Technologies In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 21. Agilent Technologies In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Cyprotex Corporate Information, Head Office, and Major Competitors

Table 23. Cyprotex Major Business

Table 24. Cyprotex In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 25. Cyprotex In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Covance Corporate Information, Head Office, and Major Competitors

Table 27. Covance Major Business

Table 28. Covance In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 29. Covance In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Bioreliance Corporate Information, Head Office, and Major Competitors

Table 31. Bioreliance Major Business

Table 32. Bioreliance In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 33. Bioreliance In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Catalent Corporate Information, Head Office, and Major Competitors

Table 35. Catalent Major Business

Table 36. Catalent In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 37. Catalent In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Charles River Laboratories International Corporate Information, Head Office, and Major Competitors

Table 39. Charles River Laboratories International Major Business

Table 40. Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 41. Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Alere Corporate Information, Head Office, and Major Competitors

Table 43. Alere Major Business

Table 44. Alere In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 45. Alere In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Eurofins Scientific Corporate Information, Head Office, and Major Competitors

Table 47. Eurofins Scientific Major Business

Table 48. Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 49. Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Life Technologies Corporation Corporate Information, Head Office, and Major Competitors

Table 51. Life Technologies Corporation Major Business

Table 52. Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 53. Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Quest Diagnostics Corporate Information, Head Office, and Major Competitors

Table 55. Quest Diagnostics Major Business

Table 56. Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Product and Solutions

Table 57. Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Global In-Vitro Toxicology and Toxicity Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 59. Global In-Vitro Toxicology and Toxicity Testing Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 60. Breakdown of In-Vitro Toxicology and Toxicity Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. In-Vitro Toxicology and Toxicity Testing Players Head Office, Products and Services Provided

Table 62. In-Vitro Toxicology and Toxicity Testing Mergers & Acquisitions in the Past Five Years

Table 63. In-Vitro Toxicology and Toxicity Testing New Entrants and Expansion Plans

Table 64. Global In-Vitro Toxicology and Toxicity Testing Revenue (USD Million) by Type (2017-2022)

Table 65. Global In-Vitro Toxicology and Toxicity Testing Revenue Share by Type (2017-2022)

Table 66. Global In-Vitro Toxicology and Toxicity Testing Revenue Forecast by Type (2023-2028)

Table 67. Global In-Vitro Toxicology and Toxicity Testing Revenue by Application (2017-2022)

Table 68. Global In-Vitro Toxicology and Toxicity Testing Revenue Forecast by Application (2023-2028)

Table 69. North America In-Vitro Toxicology and Toxicity Testing Revenue by Type (2017-2022) & (USD Million)

Table 70. North America In-Vitro Toxicology and Toxicity Testing Revenue by Type (2023-2028) & (USD Million)

Table 71. North America In-Vitro Toxicology and Toxicity Testing Revenue by Application (2017-2022) & (USD Million)

Table 72. North America In-Vitro Toxicology and Toxicity Testing Revenue by Application (2023-2028) & (USD Million)

Table 73. North America In-Vitro Toxicology and Toxicity Testing Revenue by Country (2017-2022) & (USD Million)

Table 74. North America In-Vitro Toxicology and Toxicity Testing Revenue by Country (2023-2028) & (USD Million)

Table 75. Europe In-Vitro Toxicology and Toxicity Testing Revenue by Type (2017-2022) & (USD Million)

Table 76. Europe In-Vitro Toxicology and Toxicity Testing Revenue by Type (2023-2028) & (USD Million)

Table 77. Europe In-Vitro Toxicology and Toxicity Testing Revenue by Application (2017-2022) & (USD Million)

Table 78. Europe In-Vitro Toxicology and Toxicity Testing Revenue by Application (2023-2028) & (USD Million)

Table 79. Europe In-Vitro Toxicology and Toxicity Testing Revenue by Country (2017-2022) & (USD Million)

Table 80. Europe In-Vitro Toxicology and Toxicity Testing Revenue by Country (2023-2028) & (USD Million)

Table 81. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Revenue by Type (2017-2022) & (USD Million)

Table 82. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Revenue by Type (2023-2028) & (USD Million)

Table 83. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Revenue by Application (2017-2022) & (USD Million)

Table 84. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Revenue by Application (2023-2028) & (USD Million)

Table 85. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Revenue by Region (2017-2022) & (USD Million)

Table 86. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Revenue by Region (2023-2028) & (USD Million)

Table 87. South America In-Vitro Toxicology and Toxicity Testing Revenue by Type (2017-2022) & (USD Million)

Table 88. South America In-Vitro Toxicology and Toxicity Testing Revenue by Type (2023-2028) & (USD Million)

Table 89. South America In-Vitro Toxicology and Toxicity Testing Revenue by Application (2017-2022) & (USD Million)

Table 90. South America In-Vitro Toxicology and Toxicity Testing Revenue by Application (2023-2028) & (USD Million)

Table 91. South America In-Vitro Toxicology and Toxicity Testing Revenue by Country (2017-2022) & (USD Million)

Table 92. South America In-Vitro Toxicology and Toxicity Testing Revenue by Country (2023-2028) & (USD Million)

Table 93. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Revenue by Type (2017-2022) & (USD Million)

Table 94. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Revenue by Type (2023-2028) & (USD Million)

Table 95. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Revenue by Application (2017-2022) & (USD Million)

Table 96. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Revenue by Application (2023-2028) & (USD Million)

Table 97. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Revenue by Country (2017-2022) & (USD Million)

Table 98. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. In-Vitro Toxicology and Toxicity Testing Picture

Figure 2. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type in 2021

Figure 3. Cell Culture Technology

Figure 4. High Throughput Technologies

Figure 5. Molecular Imaging Technologies

Figure 6. Omics Technologies

Figure 7. In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Application in 2021

Figure 8. Pharmaceutical Industry Picture

Figure 9. Chemical Industry Picture

Figure 10. Food Industry Picture

Figure 11. Other Picture

Figure 12. Global In-Vitro Toxicology and Toxicity Testing Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global In-Vitro Toxicology and Toxicity Testing Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Region (2017-2028)

Figure 15. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Region in 2021

Figure 16. North America In-Vitro Toxicology and Toxicity Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe In-Vitro Toxicology and Toxicity Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America In-Vitro Toxicology and Toxicity Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa In-Vitro Toxicology and Toxicity Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. In-Vitro Toxicology and Toxicity Testing Market Drivers

Figure 22. In-Vitro Toxicology and Toxicity Testing Market Restraints

Figure 23. In-Vitro Toxicology and Toxicity Testing Market Trends

Figure 24. GE Healthcare Recent Developments and Future Plans

Figure 25. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 26. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 27. Agilent Technologies Recent Developments and Future Plans

Figure 28. Cyprotex Recent Developments and Future Plans

Figure 29. Covance Recent Developments and Future Plans

Figure 30. Bioreliance Recent Developments and Future Plans

Figure 31. Catalent Recent Developments and Future Plans

Figure 32. Charles River Laboratories International Recent Developments and Future Plans

Figure 33. Alere Recent Developments and Future Plans

Figure 34. Eurofins Scientific Recent Developments and Future Plans

Figure 35. Life Technologies Corporation Recent Developments and Future Plans

Figure 36. Quest Diagnostics Recent Developments and Future Plans

Figure 37. Global In-Vitro Toxicology and Toxicity Testing Revenue Share by Players in 2021

Figure 38. In-Vitro Toxicology and Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 39. Global Top 3 Players In-Vitro Toxicology and Toxicity Testing Revenue Market Share in 2021

Figure 40. Global Top 10 Players In-Vitro Toxicology and Toxicity Testing Revenue Market Share in 2021

Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 42. Global In-Vitro Toxicology and Toxicity Testing Revenue Share by Type in 2021

Figure 43. Global In-Vitro Toxicology and Toxicity Testing Market Share Forecast by Type (2023-2028)

Figure 44. Global In-Vitro Toxicology and Toxicity Testing Revenue Share by Application in 2021

Figure 45. Global In-Vitro Toxicology and Toxicity Testing Market Share Forecast by Application (2023-2028)

Figure 46. North America In-Vitro Toxicology and Toxicity Testing Sales Market Share by Type (2017-2028)

Figure 47. North America In-Vitro Toxicology and Toxicity Testing Sales Market Share by Application (2017-2028)

Figure 48. North America In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Country (2017-2028)

Figure 49. United States In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Canada In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Mexico In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Europe In-Vitro Toxicology and Toxicity Testing Sales Market Share by Type (2017-2028)

Figure 53. Europe In-Vitro Toxicology and Toxicity Testing Sales Market Share by Application (2017-2028)

Figure 54. Europe In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Country (2017-2028)

Figure 55. Germany In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. France In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. United Kingdom In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Russia In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Italy In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Sales Market Share by Type (2017-2028)

Figure 61. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Sales Market Share by Application (2017-2028)

Figure 62. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Region (2017-2028)

Figure 63. China In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Japan In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South Korea In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. India In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Southeast Asia In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Australia In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South America In-Vitro Toxicology and Toxicity Testing Sales Market Share by Type (2017-2028)

Figure 70. South America In-Vitro Toxicology and Toxicity Testing Sales Market Share by Application (2017-2028)

Figure 71. South America In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Country (2017-2028)

Figure 72. Brazil In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Argentina In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Middle East and Africa In-Vitro Toxicology and Toxicity Testing Sales Market Share by Type (2017-2028)

Figure 75. Middle East and Africa In-Vitro Toxicology and Toxicity Testing Sales Market Share by Application (2017-2028)

Figure 76. Middle East and Africa In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Country (2017-2028)

Figure 77. Turkey In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Saudi Arabia In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. UAE In-Vitro Toxicology and Toxicity Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Methodology

Figure 81. Research Process and Data Source